Strange announcement this one. It looks like the sort of thing that somebody woke up one morning, thought hey let's do a trial, and hey let's give it a cool sounding mythological name. But no protocol, no investigator brochure, no confirmed formulation, no phase 1 unit, no CRO, woolly timelines. The trial name is misleading, it implies targeting patients with skin LE, but it's in fact a healthy volunteer trial.
4c says cash balance $2.3M at June end. Much of that will be eaten up by the proposed trial.
CEO quote is that this is a return to the clinical trials stage in "record time". Really?
Strange announcement this one. It looks like the sort of thing...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $5.496K | 45.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 74793 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 75733 | 5 |
View Market Depth
| Last trade - 10.06am 02/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |